Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis

Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis

Source: 
BioSpace
snippet: 

The U.S. Food and Drug Administration (FDA) green-lit Janssen’s Stelara for the treatment of adult patients with moderately to severely active ulcerative colitis after clinical trials demonstrated the drug helped patients achieve “clinical remission.”